Opinion
Opinion

Does Restricting Pharma Advertising Violate the First Amendment?

Does Restricting Pharma Advertising Violate the First Amendment?
FDA Commissioner Dr. Marty Makary in Washington on July 29, 2025. Saul Loeb/AFP via Getty Images
Jeffrey A. Tucker
|Updated:
0:00
Commentary

FDA secretary Marty Makary has announced new federal expectations for pharmaceutical ads on television and other media. They will face a greater obligation to list side effects and downsides of the drugs. They can no longer just mention a few and move on. We are going back to the old law that demands more disclosure of the downside.

Jeffrey A. Tucker
Jeffrey A. Tucker
Author
Jeffrey A. Tucker is the founder and president of the Brownstone Institute and the author of many thousands of articles in the scholarly and popular press, as well as 10 books in five languages, most recently “Liberty or Lockdown.” He is also the editor of “The Best of Ludwig von Mises.” He writes a daily column on economics for The Epoch Times and speaks widely on the topics of economics, technology, social philosophy, and culture. He can be reached at [email protected]
twitter